Product Description
For the treatment of pancreatic cancer. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Tetrachlorodecaoxide)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Germany | India | Indonesia | Philippines | Portugal | Sri Lanka | Thailand
Approved Indications: None
Company: Nuvo Research
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: HIV Infections|Acquired Immunodeficiency Syndrome
Phase 2: Rhinitis, Allergic|Diabetic Foot|Acquired Immunodeficiency Syndrome|HIV Infections|Pancreatic Cancer
Phase 1: Deficiency Diseases|Acquired Immunodeficiency Syndrome|Communicable Diseases|HIV Infections
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT07096830 |
TCDO-Wound | N/A |
Not yet recruiting |
Ranula|Diabetic Foot|Chronic Pain|Leg Ulcer|Wound Infection|Pressure Ulcer |
2026-07-30 |
2025-08-06 |
Primary Endpoints |
|
NCT00002119 |
222A | P1 |
Completed |
Deficiency Diseases|Acquired Immunodeficiency Syndrome|Communicable Diseases|HIV Infections |
None |
2019-03-21 |
||
NCT04372355 |
SWUEC-043/2019F | P2 |
Completed |
Diabetic Foot |
2020-04-30 |
2020-10-24 |
Primary Endpoints |
|
2013-003096-35 |
2013-003096-35 | P2 |
Completed |
Rhinitis, Allergic |
2016-02-15 |
2022-03-13 |
Treatments |
|
2007-006003-21 |
2007-006003-21 | P2 |
Completed |
Rhinitis, Allergic |
2010-11-23 |
2022-03-12 |
Treatments |
|
NCT01586468 |
WF10-07-002 | P2 |
Completed |
Rhinitis, Allergic |
2010-09-01 |
2019-03-19 |
Treatments |
|
2005-003553-27 |
2005-003553-27 | P2 |
Completed |
Pancreatic Cancer |
2008-12-15 |
2022-03-12 |
Treatments |
|
NCT00002152 |
222B | P2 |
Completed |
Acquired Immunodeficiency Syndrome|HIV Infections |
None |
2019-03-21 |
Treatments |
|
NCT00002244 |
222C | P3 |
Completed |
HIV Infections|Acquired Immunodeficiency Syndrome |
None |
2025-08-01 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
02/12/2026 |
News Article |
Sony Electronics Launches WF-1000XM6 Truly Wireless Earbuds - The Best Noise Canceling[1] with Premium Sound |
|
02/12/2026 |
News Article |
/C O R R E C T I O N -- Sony Electronics, Inc./ |
|
05/15/2025 |
News Article |
Sony Introduces the Best Noise Cancellation with the WH-1000XM6 Headphones¹ |
|
10/01/2024 |
News Article |
Sony Electronics Expands its LinkBuds Range with the LinkBuds Fit and LinkBuds Open Earbuds, and LinkBuds Speaker |